Else Nutrition, which specialises in plant-based but soy-free infant and toddler formulas, has launched in Asia-Pacific with Australia as its first stop.
Infant nutrition will take centre stage for the first session of our Growth Asia Summit 2024, with industry experts from Danone and Junlebao, and pioneering academics, sharing their latest insights into this key industry, and public health, topic.
Several major infant formula brands, including a2 milk and Danone’s Aptamil, are successfully gaining market share despite a shrinking birth rate and tighter regulatory regime in China, their latest financial results have shown.
China’s infant formula giant Feihe says group profit was down 33.5 per cent in FY23, as the country struggles with raising its birth rate despite introducing a three-child policy three years ago.
Danone’s CEO says that its business in China has been “extremely strong” in FY23 with growth propelled by its specialised nutrition portfolio, which consists of infant and medical nutrition products.
The a2 milk Company says its infant formula sales in China had increased by 1.5 per cent in the first half of FY2024, although the market had shrunk almost 14 per cent in sales.
Nicotinamide mononucleotide (NMN) is known for its longevity-related health claims, but a new observational study from Meiji claims that a higher concentration of the NMN in breast milk is linked to significantly better motor and communication skills...
Australian infant and adult milk formula firm Nutura Organic will be making its debut in Thailand through a distribution deal with major Thai food producer CP Foods.
Infants who were fed on a novel milk formula containing large milk phospholipids coated droplets in the first four months of life were found to have a body mass index (BMI) and blood pressure that were similar to breastfed infants, according to a five-year...
Demand for paediatric probiotics and nutritional supplements in mainland China declined in Q3, as parents were shopping less in pharmacies for immunity related products, according to Hong Kong-headquartered Health and Happiness Group (H&H Group).
China dairy giant Junlebao believes that the concentration of a specific variant of DHA molecules – the sn-2 DHA – plays a crucial role in the absorption and efficacy of infant formulas, and has called for industry collaboration to increase understanding...
Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local dairy giant Mengniu, announcing that they have received approvals in the past week.
Chinese authorities are imposing stricter rules on the infant formula industry, with terms such as “imported raw ingredients” and “imported milk source” banned on all product labelling from October 1, 2023.
To keep pace with the changing needs of consumers, the Vietnamese dairy company has secured the expertise of ingredient suppliers including DSM, Beneo and Chr. Hansen as it seeks to bring ‘milk powder closer to the golden standard of breast milk’.
In our monthly nutra regulatory round-up, we take a closer look at India’s requirements for vegan products and the special enforcement drive on non-compliant nutraceuticals, South Korea’s crackdown on fake health functional foods, and the impact of China’s...
New Zealand’s market for pea protein will grow 10-fold in the next decade, with key sectors being sports nutrition, infant formula, and plant-based dairy and meat alternatives, according to a report from trade officials.
Australian plant-based formula firm Sprout Organic is debuting its global expansion in Saudi Arabia and Malaysia, and eyes growth opportunity of dairy-free infant formula market in Asia-Pacific (APAC).
Taiwan’s Ministry of Health and Welfare (MOHW) has made it mandatory for infant and follow-up formula sold in the market to be printed with a new logo from January 2025.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
Two products made from Australian and New Zealand-listed The a2 Milk Company (The a2MC) were granted entry into the US market under an expedited process, the US FDA announced.
Key players in China’s infant formula industry have reported a drop in their gross profit margins in the first six months of this year, including the biggest local player Feihe, as well as Health and Happiness Group (H&H Group), and Ausnutria.
The CEO of infant formula maker Bubs Australia says that the market dynamics in the US has given the firm the confidence that it will become as significant as China.
Australia’s plant-based infant formula brand Sprout Organic aims to introduce new packaging sizes and widen its offerings in the infant formula and supplementary food categories for young children, according to its founder and CEO Selasi Berdie.
The US Food and Drug Administration (USFDA) has refuted claims that it would be postponing all infant formula import applications under its expedited scheme.
This round-up will look at developments of brands in the health and nutrition industry, including how brands such as Bubs Australia and Bellamy’s Organic have successfully gained access to the infant formula market in US, as well as Nestle Health Science’s...
Bubs Australia’s infant formula sold in the US will receive tariff concessions under a trade deal, while the firm has also announced agreements with two additional retail groups to sell its products.
Danone New Zealand and Australia-based Bellamy’s Organic are the latest to receive the US FDA’s approval to supply infant formula to the country amid its shortage crisis.
Australia’s and New Zealand’s infant formula makers have been “encouraged” by the recent success of local brand Bubs’ entry into the US amid the shortage crisis in the country, with a number now examining export opportunities.
Here we reveal new scientific findings on how turmeric supplementation could improve metabolic parameters in patients with nonalcoholic fatty liver disease (NAFLD), Indian experts’ recommendation of Lactobacillus GG (LGG) for treating diarrhoea in children,...
Meiji is expanding its infant formulas offerings in Cambodia as part of the company’s strategy in growing its overseas business – where South East Asia is identified as a region for new opportunities.
Future infant nutrition research should look into the link between nutrients and gut-brain axis and even its impacts decades later when a child reaches adulthood, instead of merely mimicking human breast milk and focusing on only height and weight gain.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
This round-up will look at trends around omnichannel strategies that health supplement brands and retailers have adopted, market opportunities for enzymes, cordyceps supplements, and the infant formula market in South Korea.
The Australian company behind the plant-based infant formula Sprout Organic has entered domestic pharmacy retailer Wholelife, and now has its sights on international expansion spanning New Zealand, Asia, Europe and the US.
Online purchase of dietary supplements flourished amid the ongoing COVID-19 pandemic, but how can brands find synergies and success in the ‘best-of-worlds’ digital and brick-and-mortar retail approach? We speak to a raft of experts to find out…
A novel infant formula which is not yet commercialised has shown to promote growth comparable to standard products, according to a clinical trial funded by Danone.
More than half of parents and pregnant women (51%) surveyed for a new WHO/UNICEF report say they have been targeted with marketing from formula milk companies, much of which is in breach of international standards on infant feeding practices.
The FDA, along with CDC and state and local partners are investigating four consumer complaints of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility received from 9/20/2021 to 1/11/2022.
This industry trends round-up features the state of Japan's functional yogurt market, factors driving the growth of China's 'underdeveloped' adult probiotic sector, and nutricosmetics consumption behaviour in Malaysia.
This round-up features South Korea’s re-evaluation of co-enzyme Q10 and other ingredients use in health functional foods, China’s push for scientific reassessment of certain health foods, and Australia’s refusal to change amygdalin rules.
China’s corporate daigou channel is witnessing high growth momentum and demand for infant formulas is exceeding pre-COVID-19 levels, according to Australian infant formula maker Bubs.
Manufacturers of ‘solid beverages’ will need to follow a set of new rules, such as changing their product labels, to prevent consumers from confusing them as health foods or infant formula, said the Chinese authorities.
Regulator Food Standards Australia New Zealand is seeking public comment on the use of 2’-O-fucosyllactose (2’-FL) produced using new genetically modified (GM) strains in infant formula products.
Probiotics have boomed in China in recent years, accounting for almost half of Asia’s sales, but the nation’s infant nutrition market has begun slow, leading experts to call for more innovation and products with added functionality.
Health and Happiness Group (H&H Group), the parent company of Swisse and Biostime, has reported slowing sales of probiotics in China, although growth remained robust in its infant formula and adult nutrition businesses in the first nine month of this...
A trial funded by Nestle has found that infant formula enriched with milk-derived oligosaccharides (MOS), a prebiotic, has helped to improve gut microbiota in babies, such as increasing the abundance of Bifidobacterium.
China has become the most trusted source of infant milk formula in the eyes of domestic consumers and Chinese parents are preferring to buy from brands that resonate, consumer surveys from the a2 Milk Company (a2MC) has revealed.
